As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step ... 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...